HK1 and infection: To determine whether pro‐inflammatory monocyte metabolism could be therapeutically targeted in lethal infection, we next treated mice with a glycolysis inhibitor, 2‐deoxy‐D‐glucose (2‐DG) (Figure 4A), a nonmetabolizing glucose analogue and competitive inhibitor of hexokinase 1.